METROPOLITAN LIFE INSURANCE CO/NY - ARBUTUS BIOPHARMA CORP ownership

ARBUTUS BIOPHARMA CORP's ticker is ABUS and the CUSIP is 03879J100. A total of 97 filers reported holding ARBUTUS BIOPHARMA CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.2%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of ARBUTUS BIOPHARMA CORP
ValueSharesWeighting
Q3 2023$12,604
-11.7%
6,2090.0%0.00%0.0%
Q2 2023$14,281
-24.1%
6,2090.0%0.00%0.0%
Q1 2023$18,813
+22.5%
6,209
-5.8%
0.00%0.0%
Q4 2022$15,362
+22.0%
6,5930.0%0.00%0.0%
Q3 2022$12,593
+154.6%
6,593
+261.3%
0.00%
Q2 2022$4,946
-70.4%
1,825
-67.5%
0.00%
-100.0%
Q1 2022$16,715
-77.5%
5,609
-70.7%
0.00%0.0%
Q4 2021$74,420
-23.7%
19,131
-15.8%
0.00%0.0%
Q3 2021$97,503
-19.3%
22,728
+77.7%
0.00%
-50.0%
Q3 2018$120,86612,7900.00%
Other shareholders
ARBUTUS BIOPHARMA CORP shareholders Q3 2023
NameSharesValueWeighting ↓
Whitefort Capital Management, LP 11,895,477$24,147,81812.66%
Two Seas Capital LP 8,280,818$16,810,0613.38%
FourWorld Capital Management LLC 1,341,907$2,724,0710.51%
Tejara Capital Ltd 180,077$365,5560.21%
Woodline Partners LP 4,719,903$9,581,4030.11%
Hudson Bay Capital Management LP 8,299,808$16,848,6100.07%
Kepos Capital LP 155,691$3160.06%
Virtus ETF Advisers LLC 40,040$81,2810.05%
Centiva Capital, LP 1,071,705$2,175,5610.05%
Kades & Cheifetz LLC 20,000$40,6000.03%
View complete list of ARBUTUS BIOPHARMA CORP shareholders